Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash from Financing Activities (2016 - 2026)

Bio-Techne has reported Cash from Financing Activities over the past 17 years, most recently at -$49.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 41.57% year-over-year to -$49.0 million; the TTM value through Dec 2025 reached -$251.7 million, down 21.05%, while the annual FY2025 figure was -$253.9 million, 107.44% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$49.0 million at Bio-Techne, down from -$44.2 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $150.8 million in Q1 2023 and troughed at -$90.5 million in Q2 2025.
  • A 5-year average of -$31.4 million and a median of -$52.9 million in 2021 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: surged 363.17% in 2021 and later crashed 282.02% in 2025.
  • Year by year, Cash from Financing Activities stood at -$53.4 million in 2021, then tumbled by 35.26% to -$72.2 million in 2022, then fell by 12.75% to -$81.4 million in 2023, then fell by 3.0% to -$83.8 million in 2024, then skyrocketed by 41.57% to -$49.0 million in 2025.
  • Business Quant data shows Cash from Financing Activities for TECH at -$49.0 million in Q4 2025, -$44.2 million in Q3 2025, and -$90.5 million in Q2 2025.